Supreme Court Nixes Novartis’ Appeal on Preemption of Punitive Damages

The Supreme Court Monday refused to hear an appeal of a case brought by Novartis, in which the drugmaker argued that punitive damages backed by juries are preempted by the 1938 FD&C Act. The rejection sets a troubling precedent for an industry beset by injury lawsuits, experts say.
Drug Industry Daily